Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Podack

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Gesundheits-Ingenieur|July 1, 1973
[Meterological data for various stations in Germany]D E Podack
The Journal of Clinical Investigation|May 1, 1990
Vitronectin binds to activated human platelets and plays a role in platelet aggregationE Asch, E Podack
Blood|July 4, 2001
Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesisZ Jiang, E Podack, R B Levy
Transplantation Proceedings|June 1, 1997
Mechanisms of rejection of nonvascularized grafts: the role of perforin and FasG Selvaggi, C Ricordi, E Podack, et al.
Biochemical and Biophysical Research Communications|September 24, 1996
A hammerhead ribozyme that cleaves perforin and fas-ligand RNAs in vitroZ Du, C Ricordi, E Podack, et al.
Transplantation Proceedings|June 1, 1997
In vitro characterization of hammerhead ribozymes against perforin and fas-ligand RNAZ Du, C Ricordi, E Podack, et al.
Scandinavian Journal of Immunology|March 1, 1992
Molecular events in late stages of T-cell functional maturationP J Nelson, R L Geller, E Podack, et al.
The American Journal of Pathology|April 1, 1987
Localization of S protein and its relationship to the membrane attack complex of complement in renal tissueR J Falk, E Podack, A P Dalmasso, et al.
Human Gene Therapy|March 1, 1995
Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancerP A Cassileth, E Podack, K Sridhar, et al.
Human Gene Therapy|August 7, 1998
Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymesZ Du, C Ricordi, L Inverardi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Gesundheits-Ingenieur|July 1, 1973
[Meterological data for various stations in Germany]D E Podack
The Journal of Clinical Investigation|May 1, 1990
Vitronectin binds to activated human platelets and plays a role in platelet aggregationE Asch, E Podack
Blood|July 4, 2001
Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesisZ Jiang, E Podack, R B Levy
Transplantation Proceedings|June 1, 1997
Mechanisms of rejection of nonvascularized grafts: the role of perforin and FasG Selvaggi, C Ricordi, E Podack, et al.
Biochemical and Biophysical Research Communications|September 24, 1996
A hammerhead ribozyme that cleaves perforin and fas-ligand RNAs in vitroZ Du, C Ricordi, E Podack, et al.
Transplantation Proceedings|June 1, 1997
In vitro characterization of hammerhead ribozymes against perforin and fas-ligand RNAZ Du, C Ricordi, E Podack, et al.
Scandinavian Journal of Immunology|March 1, 1992
Molecular events in late stages of T-cell functional maturationP J Nelson, R L Geller, E Podack, et al.
The American Journal of Pathology|April 1, 1987
Localization of S protein and its relationship to the membrane attack complex of complement in renal tissueR J Falk, E Podack, A P Dalmasso, et al.
Human Gene Therapy|March 1, 1995
Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancerP A Cassileth, E Podack, K Sridhar, et al.
Human Gene Therapy|August 7, 1998
Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymesZ Du, C Ricordi, L Inverardi, et al.
Pageof 2